Mark S. Butler is a drug development expert specializing in natural product-inspired therapeutics and bioproducts, with over three decades of experience across academia, biotech, and pharmaceutical R&D. He has led and contributed to multiple natural product and anti-infective discovery and development programmes and has worked with the World Health Organization (WHO) on its Global Action Plan on antimicrobial resistance (AMR). He is currently Director of MSBChem Consulting and a casual academic at UQ, advising on AMR, drug development strategy, and bioproduct innovation.
Mark holds a PhD in Natural Product Chemistry from the University of Melbourne and an MBA from the University of Queensland (UQ). He has authored over 140 scientific publications and is a multiple-year Clarivate Highly Cited Researcher.